286836-32-6 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(benzofuran-5-yl)propan-2-one is utilized as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drug molecules. Its unique structure allows for the creation of compounds with potential therapeutic properties.
Used in Organic Compound Production:
In the chemical industry, 1-(benzofuran-5-yl)propan-2-one serves as a precursor in the production of a variety of organic compounds, leveraging its reactivity to form new substances with specific applications.
Used in Research and Development:
1-(benzofuran-5-yl)propan-2-one is also employed in research and development settings, where its unique properties are explored for potential uses in creating novel synthetic substances and understanding its chemical behavior.
Safety and Handling:
Due to the potential hazards and risks associated with 1-(benzofuran-5-yl)propan-2-one, it is essential to handle and store this chemical with appropriate safety measures to ensure the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 286836-32-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,6,8,3 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 286836-32:
(8*2)+(7*8)+(6*6)+(5*8)+(4*3)+(3*6)+(2*3)+(1*2)=186
186 % 10 = 6
So 286836-32-6 is a valid CAS Registry Number.
286836-32-6Relevant academic research and scientific papers
ADVANTAGEOUS BENZOFURAN COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT
-
Page/Page column 274; 286; 287; 306, (2021/12/31)
Pharmaceutically active benzofuran compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes benzofuran compounds, compositions, and methods for generally modulating central nervous system activity and treating central nervous system disorders.
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
-
Page/Page column 33-34, (2010/11/08)
The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12 are as described in the specification.
